Advertisement
Canada markets closed
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7323
    +0.0025 (+0.35%)
     
  • CRUDE OIL

    83.81
    +1.00 (+1.21%)
     
  • Bitcoin CAD

    88,554.55
    +1,117.70 (+1.28%)
     
  • CMC Crypto 200

    1,396.71
    +14.14 (+1.02%)
     
  • GOLD FUTURES

    2,343.90
    +5.50 (+0.24%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ

    15,611.76
    -100.99 (-0.64%)
     
  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6823
    +0.0004 (+0.06%)
     

Bristol-Myers CEO: We're 'one step closer to creating that great company' with Celgene

"When the two companies come together, we'll have two growing businesses," Caforio said in an interview with "Mad Money's" Jim Cramer. It's going to be a great company, [will] create value for shareholders, [and will be] very good for patients," he said. "I'm focused and we're focused on creating value for the long term and we're getting to work on the integration ... I believe the value of the new company will be demonstrated rapidly," he says.